Sudan Virus Vaccine Safety Study for Healthy Adults
Part of Infections clinical trials.
This study tests a new experimental vaccine designed to protect against Sudan virus, a rare but serious disease. Researchers will check if the vaccine is safe and helps your immune system fight off the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and in good overall health
- You are willing to use condoms consistently for 3 months after receiving the vaccine
- If you can become pregnant, you must use reliable birth control for 2 weeks before and 3 months after the vaccine
- You have not received certain vaccines (like live flu vaccine) within the past 2–4 weeks
- You do not have HIV, hepatitis B or C, or other serious infections
- You are willing to take an HIV test and receive counseling about sexual health
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine to protect against Marburg virus, a rare but serious infection. The vaccine uses a weakened virus to teach your body to fight the Marburg virus, and researchers are checking if it is safe and how well it works.
This study tests how safe a Rift Valley fever (RVF) vaccine is and how strongly it triggers the body’s immune response. You may be eligible if you are at risk of RVF exposure and your blood test shows you don’t already have strong protection.
This study tests a new vaccine called V4020 designed to protect against Venezuelan equine encephalitis (VEE), a virus spread by mosquitoes. The vaccine is given to healthy adults to see if it is safe and creates a good immune response.
This trial tests an Ebola vaccine in healthy people from local communities to see how it works and how safe it is. You may be able to join if you meet age, health, and vaccination/medication rules and can follow pregnancy-prevention and consent requirements.
This study tests a new RSV vaccine to see if it is safe for healthy adults. It uses mRNA technology to help your body build protection against RSV, a common respiratory virus.
This study tests an experimental HIV vaccine that uses tiny particles and mRNA technology in healthy adults. If you qualify, you'll help researchers see if it's safe and if it triggers an immune response.
Hear when a new Sudan Virus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.